Accelerating the development of Continuous Glucose Monitoring (CGM) devices
Transforming diabetes care with scalable, innovative solutions
Continuous glucose monitoring (CGM) devices are transforming diabetes care, improving outcomes, and reducing healthcare burdens. As demand grows, developing CGM devices that are reliable, scalable, and fit well into the expanding diversity of user needs presents complex challenges that require interrelated multidisciplinary expertise to solve.
Meeting the demands of a rapidly changing market
The CGM market is growing rapidly, driven by expanded access to Type 2 diabetes patients, innovations such as over-the-counter wellness devices, and a growing interest in the real-time monitoring of additional biomarkers. These shifts bring new challenges for medical device manufacturers, from integrating novel measurement modalities, addressing new and diverse user needs, to ensuring robustness and reliability at scale.
Accelerating CGM development requires a comprehensive approach that balances technical innovation with practical implementation. Successful products must strike the right balance of delivering precise sensing technologies while addressing considerations for manufacturability, scalability, usability, and cost.
For wearable devices, this often means optimising size, power efficiency, and user comfort. Implantable devices must also address stringent requirements for biocompatibility, long-term stability, and ease of implantation.
The key to advancing both is tackling challenges such as data accuracy, power consumption, and long-term reliability, while navigating the trade-offs between technical performance and user needs. By proactively identifying risks and optimising designs early, development teams can reduce costly delays and ensure their devices are ready to meet the evolving demands of a growing user base.
Below we delve deeper into these critical topics - exploring the challenges, uncovering new insights, and sharing strategies to advance CGM technologies for the diabetes treatments of tomorrow.
Find out how TTP's Biosensor product development team can support your product ambitions.
Meet us at
TTP’s scientific team ‘went the extra mile’ time and again by asking questions, identifying and pursuing pathways, and presenting complete solutions to unforeseen findings.
Dr Paul Goode
Glucotrack, USA
TTP played an essential role in assessing the feasibility of an exciting new Continuous Glucose Monitoring (CGM) concept discovered at Carbometrics Limited. The team are hugely experienced, professional and efficient. They are well versed in the immense challenges that pave the way from concept to product and we learned a huge amount working with them.
Andy Chapman
CEO and Co-founder of Carbometrics
Developing a novel CGM sensor is a complex challenge that demands rigorous testing from the outset. Our automated platform provides a robust, scalable solution, avoiding the inconsistencies that can arise from manual testing, generating high quality test data to accelerate development and build confidence before moving to in-vivo trials. Automated sensor testing is just one way we support our clients in their developments—our assignments range from tackling early-stage concepts and analysis of the fundamentals of sensor operation, designing and building development prototypes, to refining manufacturing processes.
Justin Buckland
Biosensing technical lead, TTP
Our areas of focus:
Medical Devices & Drug Delivery
Our approach and capabilities
We deliver across the entire life of a project, from opportunity discovery to production engineering. Discover how our interdisciplinary teams of experts collaborate to tackle the toughest product development challenges.
Our campus and facilities
Our award-winning campus has been designed with a clear vision. To create space which can suport our people and our clients as we develop and deliver the very best technology solution.
Software capability at TTP
Engaged in all stages of software and product development, our software capability at TTP covers the full spectrum—from in-depth analysis and system architecture to prototype design, implementation, and test development.
Manufacturing capability at TTP
Working seamlessly with our development teams, we take clients' products through prototype builds, clinical trials, pilot manufacture and more. Using TTP Manufacturing reduces uncertainty, risk and time to market for our clients.
Meet some of the team
Justin Buckland
